CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)

Published:2023-12-04 Issue:4 Volume:167 Page:335-339
ISSN:1213-8118
Container-title:Biomedical Papers
language:
Short-container-title:BIOMED PAP

Author:

Drosslerova Marie,Sterclova Martina,Taskova Alice,Hytych Vladislav,Richterova Eva,Bruzova Magdalena,Spunda Miloslav,Komarc Martin,Koziar Vasakova Martina

Publisher

Palacky University Olomouc

Subject

General Biochemistry, Genetics and Molecular Biology

Link

http://biomed.papers.upol.cz/doi/10.5507/bp.2022.050.pdf

Reference23 articles.

1. Present Experience and Perspectives of Immunotherapy of Lung Cancer

2. The immune contexture in human tumours: impact on clinical outcome

3. The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

4. Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation

5. CCL2 is critical for immunosuppression to promote cancer metastasis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt/β-Catenin signaling pathway;Cytokine;2024-08

2. Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis;Biomedicines;2023-11-21

3. Study on potential differentially expressed genes in idiopathic pulmonary fibrosis by bioinformatics and next generation sequencing data analysis;2023-09-20